Early Treatment With Single Dose Of Pegylated Interferon Lambda Reduces Risk For Hospitalization In Highly Vaccinated Population Of Outpatients With COVID-19, Trial Finds

USA Today (2/8, Weintraub) reports, “An experimental COVID-19 antiviral appears to be effective at preventing hospitalizations without some of the downsides of other treatments,” according to a trial published in The New England Journal of Medicine. This...